Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2

por Lombardi, Ludovica, Maiorca, Francesca, Marrapodi, Ramona, Sabetta, Annamaria, Scafa, Noemi, Pallucci, Davide, Miglionico, Marzia, Romiti, Giulio Francesco, Corica, Bernadette, Piconese, Silvia, Polimeni, Antonella, Pulcinelli, Fabio, Cangemi, Roberto, Visentini, Marcella, Basili, Stefania, Stefanini, Lucia
Publicado 2023

Thromboinflammation in long COVID—the elusive key to postinfection sequelae?

por Nicolai, Leo, Kaiser, Rainer, Stark, Konstantin
Publicado 2023

2023 Montréal Congress welcome editorial

por Kahn, Susan R., Rodger, Marc A.
Publicado 2023

Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation

por Jarrahi, Abbas, Khodadadi, Hesam, Moore, Nicholas S., Lu, Yujiao, Awad, Mohamed E., Salles, Evila L., Vaibhav, Kumar, Baban, Babak, Dhandapani, Krishnan M.
Publicado 2023

Thrombotic Complications in Children with COVID-19 and MIS-C

por Kumar, Riten, Rivkin, Michael J., Raffini, Leslie
Publicado 2023

Coping with setbacks as early career professionals: transforming negatives into positives

por Iding, Aaron F.J., Kohli, Shrey, Dunjic Manevski, Sofija, Sayar, Zara, Al Moosawi, Muntadhar, Armstrong, Paul C.
Publicado 2023

Is there a role for the ACE2 receptor in SARS‐CoV‐2 interactions with platelets?

por Campbell, Robert A., Boilard, Eric, Rondina, Matthew T.
Publicado 2021

Tissue factor upregulation is associated with SARS‐CoV‐2 in the lungs of COVID‐19 patients

por Subrahmanian, Sandeep, Borczuk, Alain, Salvatore, Steven, Fung, Kar‐Ming, Merrill, Joan T., Laurence, Jeffrey, Ahamed, Jasimuddin
Publicado 2021

Corrigendum

Publicado 2022

Hypoxia—An overlooked trigger for thrombosis in COVID‐19 and other critically ill patients

por Thachil, Jecko
Publicado 2020

Response to “Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance and their limitation”: Don’t throw the baby out with the bath...

por Nougier, Christophe, Benoit, Remi, Dargaud, Yesim
Publicado 2020

Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”

por Richardson, Edward, Carlo‐Stella, Carmelo, Jara, Ruben, Vlodavsky, Israel, Iacobelli, Massimo, Fareed, Jawed, Mo, Clifton, O'Gorman, Peter, Yanik, Gregory, Palomo, Marta, Diaz‐Ricart, Maribel, Moraleda, Jose M.
Publicado 2020

Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID‐19: Response from Original Authors Susen, et al.

por Susen, Sophie, Rauch, Antoine, Lenting, Peter J.
Publicado 2020

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”

por Coto‐Hernández, Rubén, Fábregas Ruano, María Teresa
Publicado 2020

Issue Information

Publicado 2020

Issue Information

Publicado 2020

Issue Information

Publicado 2020

Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis: Response from original authors Pola et al

por Porfidia, Angelo, Santoliquido, Angelo, Cammá, Giulia, Porceddu, Enrica, Pola, Roberto
Publicado 2020

What the neighbors say

Publicado 2020

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'

por Tang, Ning
Publicado 2020